Search for: "In re ACTOS Antitrust Litigation" Results 1 - 8 of 8
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Mar 2022, 2:11 pm by Robertson Noreus
Key Insight: On plaintiff’s motion to compel, the magistrate judge ruled that defendant Takeda was to produce “all responsive ESI to Plaintiffs, including earlier-in-time emails. [read post]
9 Aug 2011, 4:00 am by Maxwell Kennerly
The original for this post is Lawyer Branding And The Race For Actos Bladder Cancer Clients at Litigation & Trial. [read post]
3 Jun 2010, 5:35 am
(Spicy IP) Wellbutrin (Bupropion) – US: Pennsylvania District Court decision signals a new turn in the generic drug preemption debate; a tough pill to swallow for the generic industry: In re Budeprion XL Marketing & Sales Litigation (FDA Law Blog)   [read post]
15 Sep 2010, 2:40 am by Kelly
Highlights this week included: 2nd Circuit denies en banc reconsideration in Cipro case: In re Ciprofloxacin Antitrust Litigation (Patent Docs) (FDA Law Blog) (IPBiz) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
24 Mar 2016, 5:32 am
  See In re Biomet M2a Magnum Hip Implant Products Liability Litigation, 2013 WL 6405156, at *2 (N.D. [read post]
3 May 2014, 8:56 am by Schachtman
In litigation, each side is expected to “cherry pick” the favorable evidence, and ignore or flyblow the contrary evidence. [read post]
15 Sep 2011, 4:06 am by Maxwell Kennerly
If we don’t exercise that reasonable care, we’re negligent, and we’re responsible to pay for the damage we cause. [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]